Cognitive Market Research projects that The Global market for Chlorpheniramine Maleate will reach a value of USD 518.02 million in 2023 and increase at a compound annual growth rate (CAGR) of 5.00% between 2023 and 2030.
North America Chlorpheniramine Maleate held the major market of more than 40% of the global revenue with a market size of USD 207.28 million in 2023 and will grow at a compound annual growth rate (CAGR) of 3.2% from 2023 to 2030.
Europe Chlorpheniramine Maleate accounted for a share of over 30% of the global market size of USD 155.46 million in 2023.
Asia Pacific Chlorpheniramine Maleate market of more than 5% of the global revenue with a market size of USD 25.91 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.4% from 2023 to 2030.
South America Chlorpheniramine Maleate held the major market of more than 2% of the global revenue with a market size of USD 10.36 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2023 to 2030.
Middle East and Africa Chlorpheniramine Maleate held the major market of more than 2% of the global revenue with a market size of USD 10.36 million in 2023 and will grow at a compound annual growth rate (CAGR) of 4.7% from 2023 to 2030.
The demand for Chlorpheniramine Maleate is rising due to the numerous strategies adopted by key participants.
Demand for tablet type remains higher in the Chlorpheniramine Maleate market.
The hospital pharmacies category held the highest Chlorpheniramine Maleate market revenue share in 2023.
